Interleukin-21: A pleiotropic mediator of immunity and inflammation with broad therapeutic potential

0Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Interleukin-21 (IL-21) is a member of the family of cytokines that share the common cytokine receptor γ-chain, γ c. IL-21 plays critical roles in the differentiation and function of multiple lymphoid and myeloid lineages. In this chapter, we review the inflammatory and immunosuppressive activities of this cytokine and the specific mechanisms by which this cytokine regulates both the innate and adaptive immune responses. Despite the fact that IL-21 and its receptor were only identified in 2000, a tremendous amount has been learned already, leading to the development of potential therapeutic approaches to cancer as well as potentially allowing for the specific manipulation of IL-21 effects in a spectrum of autoimmune diseases, allergic responses, and viral infections.

Cite

CITATION STYLE

APA

Spolski, R., & Leonard, W. J. (2014). Interleukin-21: A pleiotropic mediator of immunity and inflammation with broad therapeutic potential. In Cytokine Frontiers: Regulation of Immune Responses in Health and Disease (pp. 125–146). Springer Japan. https://doi.org/10.1007/978-4-431-54442-5_5

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free